Serum prostate-specific antigen concentration is a powerful predictor of acute urinary retention and need for surgery in men with clinical benign prostatic hyperplasia

Urology

Volumn 53, Issue 3, 1999, Pages 473-480

  Roehrborn, Claus G ^a,j   McConnell, John D ^a   Lieber, Michael ^b   Kaplan, Steven ^c   Geller, Jack ^d   Malek, Gholem H ^e   Castellanos, Ronald ^f   Coffield, Scott ^g   Saltzman, Brian ^h   Resnick, Martin ⁱ   Waldstreicher, Joanne ^j  

^a UNIVERSITY OF TEXAS AT DALLAS   (United States)

^b MAYO CLINIC   (United States)

^c New York Presbyterian Hospital Columbia University Medical Center   (United States)

^d Jackson Foundation   (United States)

^e Fort Myers Radiology Associates   (United States)

^f SCOTT AND WHITE MEMORIAL HOSPITAL   (United States)

^g BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^h CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

ⁱ SCRIPPS MERCY HOSPITAL   (United States)

^j MERCK RESEARCH LABORATORIES   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

FINASTERIDE; PROSTATE SPECIFIC ANTIGEN;

ADULT; ANTIGEN DETECTION; ARTICLE; DISEASE COURSE; DISEASE MARKER; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSTATE HYPERTROPHY; SYMPTOM; TREATMENT OUTCOME; TREATMENT PLANNING; TUMOR VOLUME; URINE RETENTION;

ACUTE DISEASE; DOUBLE-BLIND METHOD; ENZYME INHIBITORS; FINASTERIDE; HUMANS; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC HYPERPLASIA; URINARY RETENTION;

EID: 0033104375     PISSN: 00904295     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0090-4295(98)00654-2     Document Type: Article

References (11)

1. Girman C.J., Epstein R.S., Jacobsen S.J., et al. Natural history of prostatism impact of urinary symptoms on quality of life in 2115 randomly selected community men . Urology. 44:1994;825-831.
2. Barry M.J., Fowler F.J. Jr, Bin L., et al. The natural history of patients with benign prostatic hyperplasia as diagnosed by North American urologists. J Urol. 157:1997;10-15.
3. Jacobsen S.J., Jacobson D.J., Girman C.J., et al. Natural history of prostatism risk factors for acute urinary retention . J Urol. 158:1997;481-487.
4. Guess H.A. Benign prostatic hyperplasia antecedents and natural history . Epidemiol Rev. 14:1992;131-153.
5. Oesterling J.E. Benign prostatic hyperplasia a review of its histogenesis and natural history . Prostate Suppl. 6:1996;67-73.
6. Wasson JH, Reda DJ, Bruskewitz RC, et al, for the Veterans Affairs Cooperative Study Group on Transurethral Resection of the Prostate . A comparison of transurethral surgery with watchful waiting for moderate symptoms of benign prostatic hyperplasia. N Engl J Med. 332:1995;75-79.
7. Boyle P., Gould A.L., Roehrborn C.G. Prostate volume predicts outcome of treatment of benign prostatic hyperplasia with finasteride meta-analysis of randomized clinical trials . Urology. 48:1996;398-405.
8. McConnell JD, Bruskewitz R, Walsh P, et al, for the Finasteride Long-Term Efficacy and Safety Study Group . The effect of finasteride on the risk of acute urinary retention and the need for surgical treatment among men with benign prostatic hyperplasia (see comments). N Engl J Med. 338:1998;557-563.
9. Roehrborn C.G., Girman C.J., Rhodes T., et al. Correlation between prostate size estimated by digital rectal examination and measured by transrectal ultrasound. Urology. 49:1997;548-557.
10. Roehrborn C.G., Boyle P., Gould A.L., et al. Serum prostate-specific antigen as a predictor of prostate volume in men with benign prostatic hyperplasia. Urology. 53:1999;581-589.
11. Hanley J.A., McNeil B.J. The meaning and use of the area under a receiver operating characteristic (ROC) curve. Radiology. 143:1982;29-36.